XML 44 R33.htm IDEA: XBRL DOCUMENT
v3.21.2

Revenue (Details) $ in Millions | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 30, 2021 USD ($) segment | Jun. 30, 2020 USD ($) segment | Jun. 30, 2021 USD ($) segment | Jun. 30, 2020 USD ($) segment
Revenue |  |  |  |
Number of reportable segments | segment | 4 | 4 | 4 | 4
Net sales | $ 10,223 | $ 7,328 | $ 20,679 | $ 15,054
U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 3,581 | 2,638 | 7,419 | 5,494
Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 6,642 | 4,690 | 13,260 | 9,560
Established Pharmaceutical Products |  |  |  |
Revenue |  |  |  |
Net sales | 1,180 | 1,013 | 2,250 | 2,057
Established Pharmaceutical Products | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 1,180 | 1,013 | 2,250 | 2,057
Nutritional Products |  |  |  |
Revenue |  |  |  |
Net sales | 2,108 | 1,883 | 4,144 | 3,787
Nutritional Products | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 873 | 808 | 1,709 | 1,620
Nutritional Products | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 1,235 | 1,075 | 2,435 | 2,167
Diagnostic Products |  |  |  |
Revenue |  |  |  |
Net sales | 3,247 | 1,994 | 7,261 | 3,820
Diagnostic Products | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 1,155 | 857 | 2,796 | 1,660
Diagnostic Products | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 2,092 | 1,137 | 4,465 | 2,160
Medical Devices |  |  |  |
Revenue |  |  |  |
Net sales | 3,666 | 2,423 | 6,986 | 5,360
Medical Devices | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 1,538 | 966 | 2,889 | 2,199
Medical Devices | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 2,128 | 1,457 | 4,097 | 3,161
Other |  |  |  |
Revenue |  |  |  |
Net sales | 22 | 15 | 38 | 30
Other | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 15 | 7 | 25 | 15
Other | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 7 | 8 | 13 | 15
Key Emerging Markets | Established Pharmaceutical Products |  |  |  |
Revenue |  |  |  |
Net sales | 915 | 764 | 1,736 | 1,577
Key Emerging Markets | Established Pharmaceutical Products | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 915 | 764 | 1,736 | 1,577
Other | Established Pharmaceutical Products |  |  |  |
Revenue |  |  |  |
Net sales | 265 | 249 | 514 | 480
Other | Established Pharmaceutical Products | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 265 | 249 | 514 | 480
Pediatric Nutritionals | Nutritional Products |  |  |  |
Revenue |  |  |  |
Net sales | 1,093 | 1,024 | 2,159 | 2,113
Pediatric Nutritionals | Nutritional Products | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 528 | 484 | 1,036 | 1,002
Pediatric Nutritionals | Nutritional Products | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 565 | 540 | 1,123 | 1,111
Adult Nutritionals | Nutritional Products |  |  |  |
Revenue |  |  |  |
Net sales | 1,015 | 859 | 1,985 | 1,674
Adult Nutritionals | Nutritional Products | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 345 | 324 | 673 | 618
Adult Nutritionals | Nutritional Products | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 670 | 535 | 1,312 | 1,056
Core Laboratory | Diagnostic Products |  |  |  |
Revenue |  |  |  |
Net sales | 1,306 | 987 | 2,488 | 1,976
Core Laboratory | Diagnostic Products | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 283 | 289 | 554 | 556
Core Laboratory | Diagnostic Products | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 1,023 | 698 | 1,934 | 1,420
Molecular | Diagnostic Products |  |  |  |
Revenue |  |  |  |
Net sales | 290 | 359 | 737 | 498
Molecular | Diagnostic Products | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 94 | 144 | 269 | 209
Molecular | Diagnostic Products | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 196 | 215 | 468 | 289
Point of Care | Diagnostic Products |  |  |  |
Revenue |  |  |  |
Net sales | 137 | 118 | 266 | 256
Point of Care | Diagnostic Products | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 97 | 79 | 189 | 182
Point of Care | Diagnostic Products | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 40 | 39 | 77 | 74
Rapid Diagnostics | Diagnostic Products |  |  |  |
Revenue |  |  |  |
Net sales | 1,514 | 530 | 3,770 | 1,090
Rapid Diagnostics | Diagnostic Products | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 681 | 345 | 1,784 | 713
Rapid Diagnostics | Diagnostic Products | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 833 | 185 | 1,986 | 377
Rhythm Management | Medical Devices |  |  |  |
Revenue |  |  |  |
Net sales | 567 | 401 | 1,086 | 875
Rhythm Management | Medical Devices | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 269 | 185 | 510 | 413
Rhythm Management | Medical Devices | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 298 | 216 | 576 | 462
Electrophysiology | Medical Devices |  |  |  |
Revenue |  |  |  |
Net sales | 487 | 299 | 918 | 687
Electrophysiology | Medical Devices | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 209 | 120 | 388 | 284
Electrophysiology | Medical Devices | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 278 | 179 | 530 | 403
Heart Failure | Medical Devices |  |  |  |
Revenue |  |  |  |
Net sales | 227 | 158 | 421 | 361
Heart Failure | Medical Devices | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 168 | 115 | 313 | 267
Heart Failure | Medical Devices | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 59 | 43 | 108 | 94
Vascular | Medical Devices |  |  |  |
Revenue |  |  |  |
Net sales | 697 | 481 | 1,332 | 1,106
Vascular | Medical Devices | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 246 | 168 | 465 | 398
Vascular | Medical Devices | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 451 | 313 | 867 | 708
Structural Heart | Medical Devices |  |  |  |
Revenue |  |  |  |
Net sales | 422 | 223 | 799 | 541
Structural Heart | Medical Devices | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 191 | 91 | 360 | 227
Structural Heart | Medical Devices | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 231 | 132 | 439 | 314
Neuromodulation | Medical Devices |  |  |  |
Revenue |  |  |  |
Net sales | 210 | 106 | 394 | 283
Neuromodulation | Medical Devices | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 166 | 85 | 311 | 222
Neuromodulation | Medical Devices | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | 44 | 21 | 83 | 61
Diabetes Care | Medical Devices |  |  |  |
Revenue |  |  |  |
Net sales | 1,056 | 755 | 2,036 | 1,507
Diabetes Care | Medical Devices | U.S. |  |  |  |
Revenue |  |  |  |
Net sales | 289 | 202 | 542 | 388
Diabetes Care | Medical Devices | Int'l |  |  |  |
Revenue |  |  |  |
Net sales | $ 767 | $ 553 | $ 1,494 | $ 1,119

X
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599 + Details
Name: | us-gaap_NumberOfReportableSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=abt_EstablishedPharmaceuticalProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=abt_NutritionalProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=abt_DiagnosticProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=abt_MedicalDevicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_KeyEmergingMarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_OtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_PediatricNutritionalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_AdultNutritionalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_CoreLaboratoryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_MolecularMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_PointOfCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_RapidDiagnosticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_RhythmManagementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_ElectrophysiologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_HeartFailureMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_VascularProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_StructuralHeartMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_NeuromodulationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=abt_DiabetesCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |